CHINA PHARMA HOLDINGS, INC. Inventory Adjustments
CHINA PHARMA HOLDINGS, INC. (CPHI) had Inventory Adjustments of $1.16 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Inventory, Net
us-gaap:InventoryAdjustments · last filed 2026-08-14
- 2026-06-30: Inventory Adjustments $1.16M.
- 2026-03-31: Inventory Adjustments $1.12M.
- 2025-12-31: Inventory Adjustments $1.15M.
- 2025-09-30: Inventory Adjustments $1.09M.
| Period end | Inventory Adjustments | Inventory Adjustments as first filed |
|---|---|---|
| 2026-06-30 | $1.16M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.12M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $1.15M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $1.09M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $788.20K 10-Q · filed 2026-08-14 | $1.00M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $574.07K 10-Q · filed 2026-08-14 | $788.20K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $574.07K 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $601.54K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $481.18K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $255.59K 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $129.42K 10-K · filed 2026-04-01 | |
| 2022-12-31 | $139.68K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |